| Feb 20, 2026 |
Feb 24, 2026 |
Winningham Rick E
|
CEO |
Sell |
37.5
|
-74,975
|
-4.24%
|
✗
|
$1.5M |
| Feb 20, 2026 |
Feb 24, 2026 |
Sawaf Aziz
|
CFO |
Sell |
40.0
|
-20,672
|
-6.14%
|
✗
|
$406.4K |
| Feb 20, 2026 |
Feb 24, 2026 |
Miller Aine
|
SVP, DEV & HEAD OF IRE OFFICE |
Sell |
40.0
|
-16,851
|
-8.38%
|
✗
|
$331.3K |
| Feb 20, 2026 |
Feb 24, 2026 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Sell |
40.0
|
-20,833
|
-5.86%
|
✗
|
$409.6K |
| Feb 20, 2026 |
Feb 24, 2026 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
40.0
|
-13,929
|
-5.02%
|
✗
|
$273.8K |
| Dec 3, 2025 |
Dec 5, 2025 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
22.5
|
-31,067
|
-10.06%
|
✓
|
$582.5K |
| Nov 26, 2025 |
Dec 1, 2025 |
BROSHY ERAN
|
Director |
Sell |
7.5
|
-29,501
|
-39.76%
|
✓
|
$590K |
| Nov 20, 2025 |
Nov 24, 2025 |
Sawaf Aziz
|
CFO |
Sell |
40.0
|
-18,627
|
-5.24%
|
✗
|
$333.4K |
| Nov 20, 2025 |
Nov 24, 2025 |
Miller Aine
|
SVP, DEV & HEAD OF IRE OFFICE |
Sell |
42.5
|
-6,989
|
-3.36%
|
✗
|
$125.1K |
| Nov 20, 2025 |
Nov 24, 2025 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Sell |
40.0
|
-19,024
|
-5.08%
|
✗
|
$340.5K |
| Nov 20, 2025 |
Nov 24, 2025 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
42.5
|
-9,060
|
-2.85%
|
✗
|
$162.2K |
| Nov 19, 2025 |
Nov 21, 2025 |
Winningham Rick E
|
CEO |
Sell |
37.5
|
-56,817
|
-3.12%
|
✗
|
$1M |
| Nov 11, 2025 |
Nov 14, 2025 |
BROSHY ERAN
|
Director |
Sell |
17.5
|
-45,000
|
-18.66%
|
✓
|
$809.3K |
| Nov 11, 2025 |
Nov 13, 2025 |
BROSHY ERAN
|
Director |
Sell |
5.0
|
-59,000
|
-27.68%
|
✓
|
$1.1M |
| Aug 20, 2025 |
Aug 22, 2025 |
Winningham Rick E
|
CEO |
Sell |
45.0
|
-15,394
|
-0.84%
|
✗
|
$206.1K |
| Aug 20, 2025 |
Aug 22, 2025 |
Sawaf Aziz
|
CFO |
Sell |
42.5
|
-9,368
|
-2.57%
|
✗
|
$125.4K |
| Aug 20, 2025 |
Aug 22, 2025 |
Miller Aine
|
SVP, DEV & HEAD OF IRE OFFICE |
Sell |
42.5
|
-6,989
|
-3.25%
|
✗
|
$93.6K |
| Aug 20, 2025 |
Aug 22, 2025 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Sell |
42.5
|
-9,762
|
-2.54%
|
✗
|
$130.7K |
| Aug 20, 2025 |
Aug 22, 2025 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
42.5
|
-9,096
|
-2.78%
|
✗
|
$121.8K |
| Jul 14, 2025 |
Jul 16, 2025 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
41.3
|
-10,000
|
-2.97%
|
✓
|
$113.9K |
| Jun 23, 2025 |
Jun 25, 2025 |
Winningham Rick E
|
CEO |
Neutral |
27.5
|
-20,000
|
-1.08%
|
✗
|
- |
| Jun 13, 2025 |
Jun 17, 2025 |
Winningham Rick E
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 2, 2025 |
Jun 4, 2025 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
30.0
|
-24,000
|
-6.65%
|
✓
|
$264K |
| May 20, 2025 |
May 22, 2025 |
Winningham Rick E
|
CEO |
Sell |
45.0
|
-15,364
|
-0.82%
|
✗
|
$145.2K |
| May 20, 2025 |
May 22, 2025 |
Sawaf Aziz
|
CFO |
Sell |
42.5
|
-9,348
|
-2.50%
|
✗
|
$88.3K |
| May 20, 2025 |
May 22, 2025 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Sell |
42.5
|
-9,743
|
-2.47%
|
✗
|
$92.1K |
| May 20, 2025 |
May 22, 2025 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
42.5
|
-9,120
|
-2.46%
|
✗
|
$86.2K |
| May 19, 2025 |
May 21, 2025 |
Miller Aine
|
SVP, DEV & HEAD OF IRE OFFICE |
Sell |
65.0
|
+729
|
0.34%
|
✗
|
$91.7K |
| May 19, 2025 |
May 21, 2025 |
PAKIANATHAN DEEPIKA
|
Director |
Neutral |
90.0
|
+10,649
|
22.46%
|
✗
|
- |
| May 19, 2025 |
May 21, 2025 |
O'Connor Donal
|
Director |
Neutral |
90.0
|
+10,649
|
16.76%
|
✗
|
- |
| May 19, 2025 |
May 21, 2025 |
MITCHELL DEAN J
|
Director |
Neutral |
90.0
|
+10,649
|
13.22%
|
✗
|
- |
| May 19, 2025 |
May 21, 2025 |
GRAY SUSANNAH
|
Director |
Neutral |
90.0
|
+10,649
|
33.82%
|
✗
|
- |
| May 19, 2025 |
May 21, 2025 |
Grant Jeremy T
|
Director |
Neutral |
90.0
|
+10,649
|
47.74%
|
✗
|
- |
| May 19, 2025 |
May 21, 2025 |
BROSHY ERAN
|
Director |
Neutral |
90.0
|
+10,649
|
13.22%
|
✗
|
- |
| May 19, 2025 |
May 21, 2025 |
Smaldone Alsup Laurie
|
Director |
Neutral |
90.0
|
+10,649
|
16.55%
|
✗
|
- |
| Apr 21, 2025 |
Apr 23, 2025 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
48.8
|
-4,000
|
-1.07%
|
✓
|
$36K |
| Feb 28, 2025 |
Mar 4, 2025 |
Winningham Rick E
|
CEO |
Neutral |
55.0
|
+2,178
|
0.12%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Sawaf Aziz
|
CFO |
Neutral |
90.0
|
+75,000
|
25.07%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Miller Aine
|
SVP, DEV & HEAD OF IRE OFFICE |
Neutral |
90.0
|
+75,000
|
53.86%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Neutral |
90.0
|
+75,000
|
23.52%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Neutral |
90.0
|
+75,000
|
25.08%
|
✗
|
- |
| Feb 20, 2025 |
Feb 24, 2025 |
Winningham Rick E
|
CEO |
Sell |
40.0
|
-35,129
|
-1.84%
|
✗
|
$339.3K |
| Feb 20, 2025 |
Feb 24, 2025 |
Sawaf Aziz
|
CFO |
Sell |
42.5
|
-13,751
|
-4.39%
|
✗
|
$132.8K |
| Feb 20, 2025 |
Feb 24, 2025 |
Miller Aine
|
SVP, DEV & HEAD OF IRE OFFICE |
Sell |
42.5
|
-11,295
|
-7.50%
|
✗
|
$109.1K |
| Feb 20, 2025 |
Feb 24, 2025 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Sell |
42.5
|
-14,534
|
-4.36%
|
✗
|
$140.4K |
| Feb 10, 2025 |
Feb 24, 2025 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
42.5
|
-10,527
|
-3.40%
|
✗
|
$152.7K |
| Jan 21, 2025 |
Jan 23, 2025 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
48.8
|
-4,000
|
-1.28%
|
✓
|
$36K |
| Nov 20, 2024 |
Nov 22, 2024 |
Winningham Rick E
|
CEO |
Sell |
45.0
|
-15,997
|
-0.83%
|
✗
|
$159.5K |
| Nov 20, 2024 |
Nov 22, 2024 |
Sawaf Aziz
|
CFO |
Sell |
42.5
|
-8,477
|
-2.64%
|
✗
|
$84.5K |
| Nov 20, 2024 |
Nov 22, 2024 |
Miller Aine
|
SVP, DEV & HEAD OF IRE OFFICE |
Sell |
42.5
|
-10,076
|
-6.27%
|
✗
|
$100.5K |
| Nov 20, 2024 |
Nov 22, 2024 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Sell |
42.5
|
-9,268
|
-2.71%
|
✗
|
$92.4K |
| Nov 20, 2024 |
Nov 22, 2024 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
42.5
|
-9,178
|
-2.84%
|
✗
|
$91.5K |
| Nov 14, 2024 |
Nov 19, 2024 |
Winningham Rick E
|
CEO |
Neutral |
55.0
|
+3,193
|
0.17%
|
✗
|
- |
| Nov 11, 2024 |
Nov 13, 2024 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
48.8
|
-4,000
|
-1.22%
|
✓
|
$36K |
| Aug 20, 2024 |
Aug 22, 2024 |
Winningham Rick E
|
CEO |
Sell |
45.0
|
-15,997
|
-0.83%
|
✗
|
$131.5K |
| Aug 20, 2024 |
Aug 22, 2024 |
Sawaf Aziz
|
CFO |
Sell |
42.5
|
-8,635
|
-2.62%
|
✗
|
$71K |
| Aug 20, 2024 |
Aug 22, 2024 |
Miller Aine
|
SVP, DEV & HEAD OF IRE OFFICE |
Sell |
46.3
|
-5,201
|
-3.14%
|
✗
|
$42.8K |
| Aug 20, 2024 |
Aug 22, 2024 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Sell |
42.5
|
-9,268
|
-2.63%
|
✗
|
$76.2K |
| Aug 20, 2024 |
Aug 22, 2024 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
42.5
|
-9,222
|
-2.74%
|
✗
|
$75.8K |
| Aug 7, 2024 |
Aug 9, 2024 |
Winningham Rick E
|
CEO |
Neutral |
55.0
|
+3,252
|
0.17%
|
✗
|
- |
| Aug 7, 2024 |
Aug 9, 2024 |
Samaha Eli
|
10% Owner |
Buy |
100.0
|
+999,800
|
11.75%
|
✗
|
$7.8M |
| Jul 10, 2024 |
Jul 12, 2024 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
48.8
|
-4,000
|
-1.18%
|
✓
|
$36K |
| May 20, 2024 |
May 22, 2024 |
Winningham Rick E
|
CEO |
Sell |
45.0
|
-15,997
|
-0.82%
|
✗
|
$145.6K |
| May 20, 2024 |
May 22, 2024 |
Sawaf Aziz
|
CFO |
Sell |
42.5
|
-8,635
|
-2.55%
|
✗
|
$78.6K |
| May 20, 2024 |
May 22, 2024 |
Miller Aine
|
SVP, DEV & HEAD OF IRE OFFICE |
Sell |
46.3
|
-5,201
|
-3.04%
|
✗
|
$47.3K |
| May 20, 2024 |
May 22, 2024 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Sell |
42.5
|
-9,268
|
-2.57%
|
✗
|
$84.3K |
| May 20, 2024 |
May 22, 2024 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
42.5
|
-9,268
|
-2.65%
|
✗
|
$84.3K |
| May 15, 2024 |
May 17, 2024 |
Winningham Rick E
|
CEO |
Neutral |
55.0
|
+2,068
|
0.11%
|
✗
|
- |
| May 8, 2024 |
May 10, 2024 |
PAKIANATHAN DEEPIKA
|
Director |
Neutral |
90.0
|
+10,537
|
28.57%
|
✗
|
- |
| May 8, 2024 |
May 10, 2024 |
O'Connor Donal
|
Director |
Neutral |
90.0
|
+10,537
|
19.87%
|
✗
|
- |
| May 8, 2024 |
May 10, 2024 |
MITCHELL DEAN J
|
Director |
Neutral |
90.0
|
+10,537
|
15.05%
|
✗
|
- |
| May 8, 2024 |
May 10, 2024 |
GRAY SUSANNAH
|
Director |
Neutral |
90.0
|
+10,537
|
50.29%
|
✗
|
- |
| May 8, 2024 |
May 10, 2024 |
Grant Jeremy T
|
Director |
Neutral |
90.0
|
+10,537
|
89.54%
|
✗
|
- |
| May 8, 2024 |
May 10, 2024 |
BROSHY ERAN
|
Director |
Neutral |
90.0
|
+10,537
|
15.05%
|
✗
|
- |
| May 8, 2024 |
May 10, 2024 |
Smaldone Alsup Laurie
|
Director |
Neutral |
90.0
|
+10,537
|
19.59%
|
✗
|
- |
| May 1, 2024 |
May 3, 2024 |
Samaha Eli
|
10% Owner |
Buy |
100.0
|
+1,499,124
|
21.38%
|
✗
|
$13.1M |
| Apr 2, 2024 |
Apr 4, 2024 |
Winningham Rick E
|
CEO |
Neutral |
90.0
|
+300,000
|
18.21%
|
✗
|
- |
| Apr 2, 2024 |
Apr 4, 2024 |
Sawaf Aziz
|
CFO |
Neutral |
90.0
|
+100,000
|
41.90%
|
✗
|
- |
| Apr 2, 2024 |
Apr 4, 2024 |
Miller Aine
|
SVP, DEV & HEAD OF IRE OFFICE |
Neutral |
90.0
|
+37,500
|
28.08%
|
✗
|
- |
| Apr 2, 2024 |
Apr 4, 2024 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Neutral |
90.0
|
+100,000
|
38.36%
|
✗
|
- |
| Apr 2, 2024 |
Apr 4, 2024 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Neutral |
90.0
|
+37,500
|
12.03%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
Winningham Rick E
|
CEO |
Neutral |
45.0
|
-4,296
|
-0.26%
|
✗
|
- |
| Feb 20, 2024 |
Feb 22, 2024 |
Winningham Rick E
|
CEO |
Sell |
40.0
|
-37,196
|
-2.20%
|
✗
|
$331.8K |
| Feb 20, 2024 |
Feb 22, 2024 |
Sawaf Aziz
|
CFO |
Sell |
42.5
|
-17,036
|
-6.66%
|
✗
|
$152K |
| Feb 20, 2024 |
Feb 22, 2024 |
Miller Aine
|
SVP, DEV & HEAD OF IRE OFFICE |
Sell |
42.5
|
-11,782
|
-8.11%
|
✗
|
$105.1K |
| Feb 20, 2024 |
Feb 22, 2024 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Sell |
42.5
|
-17,595
|
-6.32%
|
✗
|
$156.9K |
| Feb 20, 2024 |
Feb 22, 2024 |
GRAHAM RICHARD A
|
SVP, RESEARCH & DEVELOPMENT |
Sell |
42.5
|
-19,294
|
-5.77%
|
✗
|
$172.1K |
| Feb 20, 2024 |
Feb 22, 2024 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
32.5
|
-19,473
|
-5.88%
|
✓
|
$173.4K |
|
Feb 16, 2024 |
Miller Aine
|
SVP, Dev & Head of IRE Office |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 21, 2023 |
Dec 26, 2023 |
Grant Jeremy T
|
Director |
Neutral |
90.0
|
+11,768
|
100.00%
|
✗
|
- |
|
Dec 26, 2023 |
Grant Jeremy T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 20, 2023 |
Nov 22, 2023 |
Winningham Rick E
|
CEO |
Sell |
45.0
|
-15,804
|
-0.93%
|
✗
|
$163.9K |
| Nov 20, 2023 |
Nov 22, 2023 |
Sawaf Aziz
|
CFO |
Sell |
42.5
|
-6,187
|
-2.36%
|
✗
|
$64.2K |
| Nov 20, 2023 |
Nov 22, 2023 |
Grimaud Brett A.
|
SVP, GEN COUNSEL AND SECRETARY |
Sell |
42.5
|
-7,363
|
-2.58%
|
✗
|
$76.4K |
| Nov 20, 2023 |
Nov 22, 2023 |
GRAHAM RICHARD A
|
SVP, RESEARCH & DEVELOPMENT |
Sell |
42.5
|
-12,630
|
-3.64%
|
✗
|
$131K |
| Nov 20, 2023 |
Nov 22, 2023 |
Farnum Rhonda
|
SVP, COMM & MEDICAL AFFAIRS |
Sell |
41.3
|
-9,360
|
-2.75%
|
✓
|
$97K |
| Nov 14, 2023 |
Nov 16, 2023 |
GRAHAM RICHARD A
|
SVP, RESEARCH & DEVELOPMENT |
Sell |
51.3
|
-2,482
|
-0.71%
|
✓
|
$25.4K |
| Oct 30, 2023 |
Nov 1, 2023 |
GRAHAM RICHARD A
|
SVP, RESEARCH & DEVELOPMENT |
Neutral |
82.5
|
+15,000
|
4.49%
|
✗
|
- |
| Oct 16, 2023 |
Oct 18, 2023 |
GRAHAM RICHARD A
|
SVP, RESEARCH & DEVELOPMENT |
Sell |
51.3
|
-2,482
|
-0.74%
|
✓
|
$22.4K |
| Sep 14, 2023 |
Sep 18, 2023 |
GRAHAM RICHARD A
|
SVP, RESEARCH & DEVELOPMENT |
Sell |
51.3
|
-2,482
|
-0.73%
|
✓
|
$24.5K |